Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms-Reference-Cited by-同舟云学术

Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms

Published:2012-08 Issue: Volume:1471 Page:13-22
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Kumar Anil,Sharma Neha,Gupta Amit,Kalonia Harikesh,Mishra Jitendriya

Funder

Council of Scientific and Industrial Research (CSIR)

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference58 articles.

1. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin;Aktas;J. Exp. Med.,2003

2. Antioxidative potential of fluvastatin via the inhibition of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity;Bandoh;Biol. Pharm. Bull.,2003

3. Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease;Bar-On;J. Neurochem.,2008

4. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease;Berman;J. Neurochem.,1999

5. The 6-hydroxydopamine model: news from past;Blandini;Parkinsonism Relat. Disord.,2008

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Options and Repurposed Drugs for Neurodegeneration;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

2. Statin use and risk of Parkinson’s disease among older adults in Japan: a nested case–control study using the Longevity Improvement and Fair Evidence study;Brain Communications;2024

3. Methamphetamine Toxicities and Clinical Management;NEJM Evidence;2023-11-28

4. Insights into the promising prospect of pharmacological approaches targeting mitochondrial dysfunction in major human diseases: At a glance;Process Biochemistry;2023-09

5. Neuroprotective potential of saroglitazar in 6‐OHDA induced Parkinson's disease in rats;Chemical Biology & Drug Design;2023-07-30